Orphan medical devices are devices that are used for a small patient population due to the rarity of the indications. Due to the smaller patient population, manufacturers face unique challenges in generating sufficient clinical data for regulatory submission. This article discusses the Humanitarian Use Device (HUD) program of the US Food and Drug Administration (FDA) and the orphan device program introduced in the EU in 2024.
